Knockdown of TUG1 Rescues Cardiomyocyte Hypertrophy Through Targeting the MiR-497/MEF2C Axis

Overview

Journal Open Life Sci

Specialty Biology

Date 2021 Apr 5

PMID 33817315

Citations 4

Authors

Guorong Zhang

Xinghua Ni

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to investigate the detailed role and molecular mechanism of long noncoding RNA (lncRNA) taurine upregulated gene 1 (TUG1) in cardiac hypertrophy. Cardiac hypertrophy was established by transverse abdominal aortic constriction (TAC) or angiotensin II (Ang II) treatment . Levels of lncRNA TUG1, miR-497 and myocyte enhancer factor 2C (MEF2C) mRNA were assessed by quantitative reverse transcriptase PCR (qRT-PCR). Western blot assay was performed to determine the expression of MEF2C protein. The endogenous interactions among TUG1, miR-497 and MEF2C were confirmed by dual-luciferase reporter and RNA immunoprecipitation assays. Our data indicated that TUG1 was upregulated and miR-497 was downregulated in the TAC rat model and Ang II-induced cardiomyocytes. TUG1 knockdown or miR-497 overexpression alleviated the hypertrophy induced by Ang II in cardiomyocytes. Moreover, TUG1 acted as a sponge of miR-497, and MEF2C was directly targeted and repressed by miR-497. miR-497 overexpression mediated the protective role of TUG1 knockdown in Ang II-induced cardiomyocyte hypertrophy. MEF2C was a functional target of miR-497 in regulating Ang II-induced cardiomyocyte hypertrophy. In addition, TUG1 regulated MEF2C expression through sponging miR-497. Knockdown of TUG1 rescued Ang II-induced hypertrophy in cardiomyocytes at least partly through targeting the miR-497/MEF2C axis, highlighting a novel promising therapeutic target for cardiac hypertrophy treatment.

Citing Articles

Posttranscriptional Regulation by Proteins and Noncoding RNAs.

Aranega A, Franco D Adv Exp Med Biol. 2024; 1441:313-339.

PMID: 38884719 DOI: 10.1007/978-3-031-44087-8_17.

Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction.

Jalink E, Schonk A, Boon R, Juni R Front Cardiovasc Med. 2024; 10:1300375.

PMID: 38259314 PMC: 10800550. DOI: 10.3389/fcvm.2023.1300375.

Overexpressing lnc240 Rescues Learning and Memory Dysfunction in Hepatic Encephalopathy Through miR-1264-5p/MEF2C Axis.

Zhang H, Yu G, Li J, Tu C, Hui Y, Liu D Mol Neurobiol. 2023; 60(4):2277-2294.

PMID: 36645630 DOI: 10.1007/s12035-023-03205-1.

Interactions between the ERK1/2 signaling pathway and PCAF play a key role in PE‑induced cardiomyocyte hypertrophy.

Mao Q, Wu S, Peng C, Peng B, Luo X, Huang L Mol Med Rep. 2021; 24(3).

PMID: 34278478 PMC: 8281443. DOI: 10.3892/mmr.2021.12275.

References

Pereira A, Clemente C, Cardoso A, Theizen T, Rocco S, Judice C . MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice. PLoS One. 2009; 4(12):e8472. PMC: 2794538. DOI: 10.1371/journal.pone.0008472. View

Wang Z, Zhang X, Ji Y, Zhang P, Deng K, Gong J . The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat Med. 2016; 22(10):1131-1139. PMC: 5053883. DOI: 10.1038/nm.4179. View

Bernardo B, Weeks K, Pretorius L, McMullen J . Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010; 128(1):191-227. DOI: 10.1016/j.pharmthera.2010.04.005. View

Rohini A, Agrawal N, Koyani C, Singh R . Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res. 2009; 61(4):269-80. DOI: 10.1016/j.phrs.2009.11.012. View

Xiao L, Gu Y, Sun Y, Chen J, Wang X, Zhang Y . The long noncoding RNA XIST regulates cardiac hypertrophy by targeting miR-101. J Cell Physiol. 2019; 234(8):13680-13692. DOI: 10.1002/jcp.28047. View

Shimizu I, Minamino T . Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016; 97:245-62. DOI: 10.1016/j.yjmcc.2016.06.001. View

Tang C, Liu F, Zhu J, Fu Y, Lin Q, Deng C . Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy. Sci Rep. 2016; 6:36146. PMC: 5087095. DOI: 10.1038/srep36146. View

Zhu Y, Feng Z, Jian Z, Xiao Y . Long noncoding RNA TUG1 promotes cardiac fibroblast transformation to myofibroblasts via miR‑29c in chronic hypoxia. Mol Med Rep. 2018; 18(3):3451-3460. DOI: 10.3892/mmr.2018.9327. View

Chen Y, Liu X, Chen L, Chen W, Zhang Y, Chen J . The long noncoding RNA XIST protects cardiomyocyte hypertrophy by targeting miR-330-3p. Biochem Biophys Res Commun. 2018; 505(3):807-815. DOI: 10.1016/j.bbrc.2018.09.135. View

10.

Kataoka M, Wang D . Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease. Cells. 2014; 3(3):883-98. PMC: 4197640. DOI: 10.3390/cells3030883. View

11.

Molkentin J, Markham B . Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo. J Biol Chem. 1993; 268(26):19512-20. View

12.

Wang L, Liu Z, Yin C, Asfour H, Chen O, Li Y . Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming. Circ Res. 2014; 116(2):237-44. PMC: 4299697. DOI: 10.1161/CIRCRESAHA.116.305547. View

13.

Wu Z, Zhao S, Li C, Liu C . LncRNA TUG1 serves an important role in hypoxia-induced myocardial cell injury by regulating the miR‑145‑5p‑Binp3 axis. Mol Med Rep. 2017; 17(2):2422-2430. PMC: 5783484. DOI: 10.3892/mmr.2017.8116. View

14.

Alonso-Montes C, Naves-Diaz M, Fernandez-Martin J, Rodriguez-Reguero J, Moris C, Coto E . New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy. Mol Biol Rep. 2012; 39(9):8777-85. DOI: 10.1007/s11033-012-1740-7. View

15.

Sato T, Yamamoto T, Sehara-Fujisawa A . miR-195/497 induce postnatal quiescence of skeletal muscle stem cells. Nat Commun. 2014; 5:4597. DOI: 10.1038/ncomms5597. View

16.

Zou X, Wang J, Tang L, Wen Q . LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p. In Vitro Cell Dev Biol Anim. 2019; 55(7):482-490. DOI: 10.1007/s11626-019-00368-x. View

17.

Munoz J, Collao A, Chiong M, Maldonado C, Adasme T, Carrasco L . The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling. Biochem Biophys Res Commun. 2009; 388(1):155-60. DOI: 10.1016/j.bbrc.2009.07.147. View

18.

Xiao Y, Zhang X, Fan S, Cui G, Shen Z . MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4. PLoS One. 2016; 11(12):e0168078. PMC: 5161464. DOI: 10.1371/journal.pone.0168078. View

19.

Duan L, Ding M, Hou L, Cui Y, Li C, Yu D . Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy. Biochem Biophys Res Commun. 2017; 484(3):598-604. DOI: 10.1016/j.bbrc.2017.01.145. View

20.

Iwakawa H, Tomari Y . The Functions of MicroRNAs: mRNA Decay and Translational Repression. Trends Cell Biol. 2015; 25(11):651-665. DOI: 10.1016/j.tcb.2015.07.011. View